Charles Peloquin, PharmD received his Bachelor of Science in Pharmacy at the University of Connecticut and his Doctor of Pharmacy degree from the Philadelphia College of Pharmacy and Science. He completed a hospital pharmacy residency at Duke University Medical Center, where he also served on the clinical staff. Charles completed a fellowship in Infectious Diseases and Pharmacokinetics at The Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital, Buffalo, N.Y. For 20 years, he was the Director of the Infectious Disease Pharmacokinetics Laboratory (IDPL) at National Jewish Medical and Research Center, Denver, CO. Chuck now serves as Professor of Pharmacy and Medicine at the University of Florida in Gainesville, where the IDPL now is located. Chuck and his lab are part of the UF Emerging Pathogens Institute. He also is a consultant to the FDA and CDC. Charles' laboratory serves as a national reference center for the determination of serum concentrations for the antimycobacterial, antifungal, and anti-HIV drugs, as well as linezolid. His research efforts focus on therapeutic drug monitoring and clinical trials for patients with advanced mycobacterial diseases.